MESO

Mesoblast Limited - ADR

15.07

USD

MESO Earnings Reports

Positive Surprise Ratio

MESO beat 8 of 11 last estimates.

73%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Mesoblast Limited - ADR earnings per share and revenue

On Feb 26, 2026, MESO reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.15 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 52.52 million, with a --% difference.

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Septerna, Inc. Common Stock

Report Date

Mar 09, 2026 For Q4 25

Estimate

-$0.25

Actual

-$0.24

Surprise

+7.26%

ADC Therapeutics SA

Report Date

Mar 10, 2026 For Q4 25

Estimate

-$0.27

Actual

-$0.04

Surprise

+85.39%

Kamada Ltd

Report Date

Mar 11, 2026 For Q4 25

Estimate

$0.07

Actual

$0.06

Surprise

-24.15%

SAB Biotherapeutics, Inc. Common Stock

Report Date

Mar 09, 2026 For Q4 25

Estimate

-$0.20

Actual

-$0.43

Surprise

-112.14%

Whitehawk Therapeutics, Inc. Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

-$0.15

Actual

-$0.34

Surprise

-116.42%

Codexis, Inc.

Report Date

Mar 11, 2026 For Q4 25

Estimate

-$0.04

Actual

$0.11

Surprise

+357.01%

Spruce Biosciences, Inc. Common Stock

Report Date

Apr 13, 2026 For Q4 25

Estimate

-$8.14

Actual

Surprise

BioNTech SE - ADR

Report Date

Mar 10, 2026 For Q4 25

Estimate

-$0.18

Actual

-$0.32

Surprise

-72.12%

Legend Biotech Corporation - ADR

Report Date

Mar 10, 2026 For Q4 25

Estimate

-$0.11

Actual

-$0.08

Surprise

+27.73%

Elutia Inc. Class A Common Stock

Report Date

Mar 11, 2026 For Q4 25

Estimate

-$0.14

Actual

-$0.14

Surprise

+1.96%

FAQ

What were Mesoblast Limited - ADR's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Mesoblast Limited - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Mesoblast Limited - ADR's Q2 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Mesoblast Limited - ADR expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Mesoblast Limited - ADR's next earnings report?

Based on -- analysts, Mesoblast Limited - ADR is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.